Alfuzosina. ..

100 आईएनआर/Number

मूल्य/उद्धरण प्राप्त करें

उत्पाद विवरण:

आण्विक सूत्र C19H27N5O4
एच एस कोड 29334900
अपवर्तक दर Not determined
उपयोग Pharmaceutical intermediate for oral dosage forms (tablets, extended-release)
स्टोरेज
पवित्रता >99.0%
सामग्रियां Alfuzosin hydrochloride
Click to view more
Share Your Product:

Request To Call Back जांच भेजें

मूल्य और मात्रा

न्यूनतम आदेश मात्रा 1

Bioavailability Approximately 49% (oral, as extended-release)
Packaging Details Double polyethylene bags placed in HDPE drum
Boiling Point Decomposes before boiling
Therapeutic Class Alpha-1 adrenergic receptor antagonist
Impurity Level NMT 0.1% (Individual impurities)
Risk Statements R36/37/38 (Irritant to eyes, respiratory system, and skin)
Stability Stable under recommended storage conditions
Warnings Avoid inhalation and contact with skin and eyes

उत्पाद की विशेषताएं

मेल्टिंग पॉइंट 194–196°C
आणविक भार 389.45 g/mol
दिखावट White crystalline powder
शेल्फ लाइफ 2 years
ग्रेड Pharmaceutical Grade
घुलनशीलता Freely soluble in water, methanol, and ethanol
ईआईएनईसीएस नं 617-530-1
स्ट्रक्चरल फॉर्मूला Refer to chemical structural diagram
प्रॉपर्टीज़ White or almost white powder, odorless, bitter taste, hygroscopic
उपयोग Pharmaceutical intermediate for oral dosage forms (tablets, extended-release)
पवित्रता >99.0%
आण्विक सूत्र C19H27N5O4
अपवर्तक दर Not determined
एच एस कोड 29334900
पीएच लेवल Neutral (approx. 7)
प्रॉडक्ट टाइप Active Pharmaceutical Ingredient (API)
सामग्रियां Alfuzosin hydrochloride
कैस नं 81403-68-1

Bioavailability Approximately 49% (oral, as extended-release)
Packaging Details Double polyethylene bags placed in HDPE drum
Boiling Point Decomposes before boiling
Therapeutic Class Alpha-1 adrenergic receptor antagonist
Impurity Level NMT 0.1% (Individual impurities)
Risk Statements R36/37/38 (Irritant to eyes, respiratory system, and skin)
Stability Stable under recommended storage conditions
Warnings Avoid inhalation and contact with skin and eyes

उत्पाद विवरण

Experience the top performance and new release of Alfuzosina, a first-rate pharmaceutical grade Alpha-1 adrenergic receptor antagonist proudly supplied in India. Exhibiting a towering purity above 99.0%, this heroic ingredient is presented as a white, odorless, crystalline powder with a bitter taste. Alfuzosina remains stable under perfect storage and features a sizzling bioavailability of approximately 49% (oral, extended-release). Packaged meticulously in double polyethylene bags within HDPE drums, it boasts minimal impurity levels (NMT 0.1%) and ensures safety with a neutral pH. It's ideal for use in treating benign prostatic hyperplasia (BPH) and crafted for pharmaceutical intermediates.

Advantages and Application Surface of Alfuzosina

Alfuzosina offers a towering advantage in the treatment of benign prostatic hyperplasia (BPH), delivering reliable symptom relief. Its application surface spans oral dosage forms, such as extended-release tablets, making it well-suited for pharmaceutical industries and healthcare providers. The product's outstanding purity and stable solid form ensure first-rate quality, while its easy solubility in water, methanol, and ethanol enhances formulation flexibility. Alfuzosina is a dependable choice for professionals seeking effective BPH interventions.

Domestic Market, Sample Policy, and Export Shipment

Alfuzosina is highly sought after in the domestic market across India, supporting trusted medicine suppliers and traders. The product is available for sample requests, with prompt shipment dispatched to clients after clear approvals. It also stands out in export markets, where robust packaging ensures transport safety. Buyers benefit from transparent policies and efficient delivery, making Alfuzosina a preferred pharmaceutical intermediate both nationally and for international shipments.

FAQ's of Alfuzosina. ..:

Q: How should Alfuzosina be stored to maintain its stability and shelf life?

A: Alfuzosina must be stored below 25C in a tightly closed container, protected from light and moisture, to ensure maximum stability and a shelf life of up to 2 years.

Q: What are the main applications of Alfuzosina in pharmaceutical formulations?

A: Alfuzosina is primarily used as an intermediate for oral dosage forms, especially extended-release tablets, in the treatment of benign prostatic hyperplasia (BPH).

Q: When is it safe to handle Alfuzosina, considering risk statements and warnings?

A: Alfuzosina can be safely handled with proper precautions, such as avoiding inhalation and contact with eyes or skin, due to its irritant properties (R36/37/38). Use protective equipment during processing.

Q: Where can Alfuzosina be supplied or dispatched from?

A: Alfuzosina is supplied and dispatched by pharmaceutical suppliers and traders in India, catering to both domestic and international markets through efficient shipment channels.

Q: What is the process for requesting a sample of Alfuzosina for testing?

A: Clients may request samples following the supplier's sample policy, with shipments dispatched promptly upon approval and compliance with quality assurance standards.

Q: How does Alfuzosina benefit patients with benign prostatic hyperplasia?

A: Alfuzosina provides effective symptom relief for patients with BPH, improving urinary flow and reducing discomfort, thanks to its potent Alpha-1 adrenergic receptor antagonism.